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Abstract
Increasing emphasis on interprofessionalism and teamwork in healthcare renders
psychologists’ collaborations critical and invites reexamination of psychologists’
roles related to medications. The Collaboration Level outlined by the APA’s Ad
Hoc Task Force is more achievable and in synch with health reform than
prescription privileges (RxP). RxP remains controversial due to training and
safety concerns, lacking support from health professionals, psychologists, and
consumers. Differences in educational preparation of psychologists relative to
prescribing professionals are discussed. Enactment of only three of 170 RxP
initiatives reveals RxP to be a costly, ineffectual agenda. Alternatives (e.g.,
integrated care, collaboration, telehealth) increase access without risks
associated with lesser medical knowledge. Concerns about RxP and the
movement toward team-based care warrant reconsideration of the profession’s
objectives regarding psychopharmacology.
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Psychologists and Medications in the Era of Interprofessional Care:
Collaboration is Less Problematic and Costly Than Prescribing

The premise that doctoral-level psychologists should prescribe psychoactive
medications to meet mental health needs that are unmet by current prescribers,
while theoretically helpful if done well, warrants reassessment as we enter an era
emphasizing team-based healthcare. Concerns about the background, breadth
and comprehensiveness of training for prescribing that the American
Psychological Association (APA) currently advocates to complement
psychologists’ doctoral training (i.e., most of which is not oriented toward
preparing to prescribe) have been raised; many psychologists believing that if
psychologists are to prescribe their knowledge and training should be equivalent
with that of other prescribers (Baird, 2007). Compromised training for prescribing
raises questions about quality and safety that pose both regulatory and public
health concerns, and uneasiness for numerous stakeholders. Consideration of
whether or not organized psychology should pursue prescriptive authority also
should be assessed within the context of existing alternatives—e.g.,
interdisciplinary care, in which psychologists collaborate with other professionals
whose medical training allows more comprehensive management of medications
(Butler et al., 2008; Institute of Medicine, Committee on Crossing the Quality
Chasm: Adaptation to Mental Health and Addictive Disorder, 2006).
This article begins with a brief review of medications, then explores the roles
of collaboration and interprofessional care in the context of increasingly
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compelling healthcare trends that provide psychologists opportunities to
contribute substantively to patient care, but that lack the controversy of the
agenda promoting prescription privileges for psychologists (RxP). We also
review some of the history and concerns about psychologist prescribing, the
relative limitations of the APA training model, and the impact of the pursuit of
prescription privileges on the field, including the limited success and substantial
costs of its legislative record.
Medication Trends
Medications serve important roles in the arsenal of mental health treatments.
According to the Substance Abuse and Mental Health Services Administration
(SAMHSA; 2012), use of psychoactive medications increased by 96% from 127.2
million prescription filled in 1998 to 248.8 million prescription filled in 2007 in the
US. In 1998, the market for adult psychoactive medication expenditures was an
estimated $10 billion. A decade later, psychoactive medication costs were
estimated around $25 billion (SAMHSA, 2012). During this same period
Americans receiving medication-only treatment for mental health problems
increased by 13.5%. By contrast, Americans getting combined psychotherapy
and medication decreased from 40.0% to 32.1%, yielding a 13.3% decrease from
55.9% to 42.6% in the percentage engaging in psychotherapy as part of their
treatment. These trends exist in the context of emerging evidence of the relative
benefits of combined treatments (e.g., Cuijpers, Dekker, Hoon, & Andersson,
2009).
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The locus of care in which psychopharmacological approaches are used for
treating mental health disorders is broad. Up to two-thirds of individuals with
mental health and/or substance use disorders are treated by physicians or other
healthcare providers in the U.S. (Wang, Lane, Olfson, Pincus, Wells, & Kessler,
2005) and internationally (Wang et al., 2007). Many additional patients who are
seen in primary care settings have sub-clinical mental health issues that may
complicate diagnosis/treatment for physical health problems (Kessler et al.,
2005). Despite the heterogeneous settings where patients obtain some type of
care, nearly 70% of individuals with mental health conditions have been
estimated to receive no treatment for their underlying mental health problems
(Kessler et al., 2005). Of the minority who do receive mental health treatment,
few are treated with evidence-based approaches that have been shown to be
effective (Wang et al., 2002; Wang et al., 2007).
The number of prescriptions written by primary care physicians for
psychotropic medications has increased dramatically since the mid 1990s
(Lieberman, 2003). Physicians, physician assistants and nurse practitioners, for
example, wrote approximately 70% of all anxiolytic prescriptions, 68% of all
antidepressant prescriptions, 57% of all prescriptions for stimulants, 43% of all
anti-psychotics, and 28% of mood stabilizers between August, 2006 and July,
2007 (DuBosar, 2009). Recent data question the efficacy of the most prescribed
psychotropic medication, antidepressants, in treating all but severe symptoms
(Fournier et al., 2010). There have been calls to re-think medications as a first
line form of treatment (Carlat, 2010) and concerns about whether medications
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might be partially responsible for worsening mental health outcomes (Whitaker,
2010) and for inducing various iatrogenic problems (e.g., (Gentile, 2011; Akiskal
& Benazzi, 2006).
Psychologists harbor a range of views of medications and what roles
psychologists might best play vis a vis medications (Hayes, Walser, & Bach,
2002).

Whereas most recognize the benefits medications confer for at least

some of their patients, many are concerned about potential problems that can be
associated with medications, such as adverse effects, risks of abuse, and trends
toward overprescribing.
Although shortages of psychiatrists have long been recognized (Pardes &
Pincus, 1983), as public acceptance of psychoactive medications has increased
demand for psychopharmaceuticals, the limited access to psychiatrists has
gained more attention. Psychologists have been remarkably silent about
advocating for increased funding for training psychiatrists, which arguably would
be the most direct solution to that problem. Instead, RxP proponents have
identified access problems to psychiatrists as a main justification for RxP.
Among psychologists, diverse views abound about how to ameliorate the
problem of patients facing barriers to providers for psychoactive prescriptions.
Advocates of RxP argue that securing prescription privileges provides
psychologists direct roles, including the “power to not prescribe, or to help wean
patients off medications” (Stambor, 2006, p. 30). On the other hand, RxP
opponents contend that collaboration and interprofessional practice are safer and
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more effective approaches by which psychologists can work in conjunction with
prescribers to effectively address patients’ health and mental health needs.
Collaboration: A Compelling Alternative to RxP
Whereas specialty mental health services are available from various mental
health professionals (psychologists, marriage and family therapist, social workers,
psychiatrists, etc.; Robiner, 2006), for individuals experiencing mental health
problems general medical settings present critical points of care within the
healthcare system. Even patients who recognize their own mental health
challenges may be reluctant to seek out specialty mental health care due to
various concerns such as finances, insurance coverage, convenience, time,
services location, referral inefficiencies, and stigma. This latter concern seems
particularly true for ethnic minorities (Snowden & Pingitore, 2002; Vega, Kolody,
Aguilar-Gaxiola, & Catalano, 1999). Providing mental health services in primary
care settings facilitates patients’ acceptance of referrals for service, provides
greater convenience of co-located services, builds on the already established
trust with primary care providers, and increasingly takes advantage of the
proximity of multiple types of providers working as a team (Frank, Bray, McDaniel,
& Heldring, 2003).
Primary care settings are important loci of mental health care delivery in that
there are a far greater number of physicians and “mid-level providers” (i.e., nurse
practitioners and physician assistants) than other mental health prescribers (i.e.,
psychiatrists, prescribing psychologists) who provide basic mental health
services. Nationally, there are an estimated 83,600 physician assistants (Bureau
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of Labor Statistics, 2010) and 105,700 nurse practitioners (Bureau of Labor
Statistics, 2012), who by virtue of their sheer numbers are likely to have a far
greater impact on meeting medication needs of populations than the relatively
small number of psychologists seeking to prescribe could.
Primary care providers are more widely distributed than mental health
professionals, who tend to cluster in urban and suburban areas, and
consequently are more likely to treat patients in rural areas (Xierali, Tong,
Petterson, Puffer, Phillips, & Blazemore, 2013). Thus, integrated care models
that incorporate professionals who are skilled to coordinate a range of treatments,
including psychological services, along with medical care by primary care
providers, are promising avenues to improve mental health care access and
outcomes (Butler et al., 2008).
Under the Patient Protection and Affordable Care Act (PPACA) and the
Wellstone-Domenici Mental Health Parity and Addiction Equity Act (MHPAEA),
more Americans will have insurance with mental health benefits covered
commensurately with general medical benefits. The PPACA has many features
intended to enhance and expand healthcare, including promotion of
interprofessional care. Consequently, interest in interprofessional collaborative
care has been burgeoning. Recently, several organizations have drafted
guidelines to support curricula to help prepare future health and mental
healthcare providers to engage in interprofessional collaboration (e.g., Institute of
Medicine, 2013). The World Health Organization (WHO; 2010) defines
collaborative practice in healthcare as occurring “when multiple health workers
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from different professional backgrounds provide comprehensive services by
working with patients, their families, …and communities to deliver the highest
quality of care across settings” (p. 13). Moreover, “A collaborative practice-ready
health worker is someone who has learned how to work in an interprofessional
team and is competent to do so (p.7)”.
The WHO considers interprofessional collaborations to be one of the most
encouraging solutions regarding healthcare access and distribution problems and
complex health-related challenges (HRSA, 2010; APA, 2013; WHO, 2010).
Indeed, a shift is underway promoting interprofessional care in healthcare teams
and the competencies clinicians need to provide team-based care
(Interprofessional Education Collaborative Expert Panel, 2011). Models for
providing integrated care (Heath, Wise, & Reynolds, 2013, March) and for
preparing psychologists to function in integrated teams are emerging (e.g., Cubic,
Mance, Turgesen, & Lamanna, 2012).
The Health Service Psychology Education collaborative supported by the
APA (2013) Blueprint for Health Service Psychology Education and Training
delineated diverse competencies for health service psychology. These include:
the “interpersonal skills and communication …to relate effectively with
professionals from other disciplines and demonstrate competence in
interprofessional collaborative practice” (p. 29) as well as the consultation
competence to “provide consultative psychological services to patients and their
families, other health care professionals, and systems related to health and

Collaboration and Prescribing

10	
   	
  

behavior” (p. 31) …and that they ”are familiar with evidence-based consulting
skills and methods…” (p. 31)
Such developments arguably render the pursuit of RxP less compelling. Noncontroversial measures are gaining ascendance, such as integrating
psychologists in diverse healthcare settings, including primary care (American
College of Neuropsychopharmacology, 2000; Bluestein & Cubic, 2009; Tovian,
2006; Frank et al., 2003). Deploying psychologists in primary care settings
where they can provide interdisciplinary care in concert with prescribing health
professionals (e.g., physicians, advanced practice nurses, physician assistants,
consulting psychiatrists) who can manage medications in the context of patients’
other healthcare, is not only less costly (Blount et al., 2007; Chomienne et al.,
2011), but also obviates the risks of enabling prescriptive authority based on a
training model considered controversial by various health professionals, including
some psychologists, as will be discussed later in this article.
Collaboration and Psychopharmacology Training
Increasing psychologists’ education related to clinical psychopharmacology is
generally accepted as having beneficial effects in enhancing how psychologists
engage patients in regard to medications (Smyer et al., 1993). However,
enhancing psychologists’ understanding about psychoactive medications has
never necessitated pressing for RxP (Smyer et al., 1993). When the APA Ad
Hoc Task Force on Psychopharmacology (Smyer et al., 1993) reviewed the
desirability and feasibility of psychopharmacology prescription privileges for
psychologists, it considered three potential levels of training for psychologists to
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consider. Level-2: Training for Collaborative Practice (a consultation-liaison
model) was outlined by the APA Task Force (Smyer et al., 1993) but has been
largely overlooked in favor of Level 3 training that provides a model for training
psychologists to prescribe. Training for collaborative practice would enhance
psychologists’ knowledge of psychopharmacology to work cooperatively with
other health professionals without taking the controversial step of seeking
independent prescribing. The collaborative level of training was more strongly
favored by psychology graduate students (77%) as an option for their own
training than prescribing (50%; Tatman et al., 1997). The Task Force recognized
that few psychologists would seek to prescribe (Smyer et al., 1993).
Nevertheless, it seems curious that APA developed an agenda seemingly
exclusively promoting RxP while consistently ignoring the collaboration model
(i.e., we are not aware of guidelines developed for collaboration related to
prescribing by other disciplines or efforts to promote the collaboration model).
Disregarding the APA Task Force’s Collaborative Practice level seems
particularly regrettable in that the APA (2007) Guidelines and Principles for
Accreditation of Programs in Professional Psychology already mandate
education and training that prepares psychologists to effectively consult with
other health and mental healthcare providers so that graduates of all accredited
programs presumably have basic skills in consultation, an important ingredient
for successful collaboration.
Moreover, collaboration is much closer to what most psychologists actually do.
According to the APA Center for Workforce Studies (APA CWS, 2009) Survey of
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Psychology Health Service Providers the vast majority of psychologists
collaborate with psychiatrists (89%), primary care physicians (79%), other
medical specialists (50%), nurse practitioners (51%), and over a quarter consult
collaborate with physician assistants (27%). Moreover, about 90% of
psychologists regularly discuss medications with physicians and the majority
provide information about medications to patients (APA CWS, 2009; Table 4a),
an activity that enhances patient care, but does not hinge on psychologists
prescribing. These practice patterns of psychologists, in conjunction with the
growing momentum of interprofessional team-based care, suggest that it is timely
to take another, more serious look at Level-2 training outlined in the APA Task
Force report (Smyer et al., 1993) as a potential means of achieving greater
consensus in how the profession could most effectively establish collaborative
roles for psychologists that capitalize on their on their clinical strengths. Our view
on this is not unique. The Canadian Psychological Association (CPA, 2010) Task
Force on Prescriptive Authority for Psychologists recently recommended that
active collaborative practice with prescribing professions was, “the optimal
standard for contemporary psychological practices” (p. 27) rather than promoting
RxP.
Psychologists’ contributions to collaborative care leverages their expertise
and recognized competencies in psychological assessment, intervention, and
consultation, and also present opportunities to undertake research that can
enhance healthcare. Psychologists who wish to prescribe with training
equivalent to other prescribers have always been free to explore more complete
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biomedical training available in other health professions (e.g., physicians,
advanced practice nurses, physician assistants). If they wish to be recognized
as providing pharmacologic interventions that would indisputably be considered
on par with other types of prescribing professionals, it is recommended that their
education and training be equivalent to it, beginning with obtaining the
undergraduate scientific training and ending with more intensive and broader
clinical medical supervised experiences. For example, the Doctor of Nursing
Practice degree, which is replacing the master’s level nurse practitioner degree,
requires a minimum of 1000 supervised clinical hours.
Consumers, employers, and healthcare organizations, such as the Institute of
Medicine (2006), are increasingly concerned with promoting quality care and
preventing avoidable medical errors. In the current climate of increasing
accountability within healthcare it is imperative that providers be sufficiently
trained to provide services that meet industry standards and that professionals
practice within the contours of their competence.
Psychopharmacology Demonstration Project (PDP)
Two decades ago the Department of Defense (DoD) undertook a pilot
Psychopharmacology Demonstration Project (PDP) training 10 military
psychologists to prescribe in a 2-year full time program. When it was cancelled,
the Government Accounting Office (GAO) report Need For More Prescribing
Psychologists Is Not Adequately Justified concluded that, “training psychologists
to prescribe medication is not adequately justified because the [Military Health
Services System] MHSS has no demonstrated need for them, the cost is
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substantial, and the benefits are uncertain.“ (p. 3). NBC news later presented its
Golden Fleece award to the project because of its poor cost effectiveness
(California Psychiatric Association, n.d.).
The final report of the Evaluation Panel of the PDP considered that,
“… a 2-year program-one year didactic, one year clinical
practicum that includes at least a 6-month inpatient rotation-can
transform licensed clinical psychologists into prescribing
psychologists who can function effectively and safely in the military
setting to expand the delivery of mental health treatment to a
variety of patients and clients.”
It also deemed the psychologist PDP graduates to be weaker medically than
psychiatrists (American College of Neuropsychopharmacology, 2000). Rather
than being assessed at the level of physicians, the PDP psychologists’ medical
knowledge was assessed at a student level, which does not allow independent
prescribing in any discipline in any jurisdiction. PDP graduates, themselves,
recommended against short cuts and reductions in required training. Most said
an intensive full-time year of clinical experience, involving inpatients, was
indispensible in addition to the comprehensive didactics. These features were
not, however, included in the APA training model that was originally developed
nor are they in the more recent iteration (APA, 2009). Similarly, they are not
systematically incorporated in contemporary clinical psychopharmacology
training programs.
APA Training Model and Current Training
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In 1996 the American Psychological Association (APA) adopted the
prescription privileges (RxP) agenda as a matter of policy, justifying it partly on
the basis of the PDP. It seeks to enable psychologists to prescribe
independently, which is not currently the case in most jurisdictions for mid-level
non-physician prescribers. APA also endorsed a psychopharmacology training
model that was shorter, less intensive, and less organized than the PDP.
Eligibility for undertaking the training to prescribe merely requires psychologists
graduate from an accredited doctoral psychology program, be licensed, and
practice as a “health services provider” psychologist (APA, 2009). Programs are
required to have 400 contact hours covering eight domains and an unspecified
length, breadth, or intensity of clinical supervised experience (APA, 2009). The
APA recommendations for education and training for prescribing is available
online (APA, 2009).
Several post-doctoral master’s-level psychopharmacology training programs
have opened, although none are associated with medical schools. Some are
highly reliant on distance learning. RxP programs are designed for psychologists
to continue to practice during the training. In contrast to the PDP, contemporary
training for psychologists to prescribe is part-time and requires no inpatient
training. For example, the Alliant International University (2012) program
advertises on its website, “Earn your degree at home on weekends.” New
Mexico State University (2011) acknowledges on its’ website that this truncated
schedule may shape course coverage of material: “We will cover as many drug
classes as we can in the time allotted.”	
  

Collaboration and Prescribing

16	
   	
  

Strikingly, the programs do not meet the APA’s (2007) own accreditation
criteria that are in effect for psychology graduate, internship, and postdoctoral
training. That is, they are not required to be carefully scrutinized externally as
are other levels of clinical training in psychology and as are other prescribing
disciplines’ training programs. Even APA’s (2009) revised psychopharmacology
training model describes training that is narrower and less rigorous than the PDP
training.
Although RxP proponents have acknowledged that the PDP training was
more consistent with core medical training models in terms of didactics focused
on biochemistry, pathophysiology, and clinical medicine than current clinical
psychopharmacology training programs (McGrath, 2010), they typically dismiss
the relevance of this training and contend that supplementary hours in postdoctoral training in psychopharmacology address these deficiencies in training.
The absence of rigorous testing of psychologists’ foundational biomedical and
scientific deficits precludes understanding their effects. We question how
sufficiently foundational deficiencies can be overcome and the advanced
knowledge and clinical experience for prescribing can be gained in relatively
abbreviated and distance learning training programs. We remain skeptical of the
proposition that psychologists might be able to master more quickly the complex
nexus of knowledge and skills for prescribing and managing medications than
learners in other disciplines.
Some might argue that the relatively cursory training for RxP currently
available is a form of “bait and switch” from the more robust PDP training that
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was used to justify RxP originally. The relatively more condensed nature of
existing training seems likely to render it inferior to that provided in the PDP as
well as relative to the training of other prescribers. It also raises questions about
the breadth, depth, and quality of such training. For example, how can
consumers and policy makers be assured what other prescribers learn in longer
time frames, but that is excluded from an abbreviated curriculum, is not important
in maximizing clinical outcomes? After all, when medications enter the human
body, they do not just affect emotional regulation within the brain, but have
broader physical effects across organ systems (Stuart & Heiby, 2007) that may
interact with other classes of medication.
Differences Between Psychology and (Other) Prescribing Disciplines
Graduate training in psychology differs substantively from other health
professions from the start. It requires neither undergraduate prerequisites nor
graduate coursework in basic scientific and biomedical domains (e.g., biology,
chemistry, organic chemistry, biochemistry, physiology, pathophysiology, etc.).
Such courses are generally recognized as foundational to understanding
biological and biochemical processes inherent in health and illness, how the
human body responds to medications, and how interactions among systems and
medications affect people (Heiby, 2010).
RxP proponents concede that among non-physician health professionals,
“…psychology has the core curriculum with probably the least overlap with
traditional medical curricula” (Fox, DeLeon, Newman, Sammons, Dunivin, &
Baker, 2009, p. 258). The training paradigms are so different that only 7% of
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psychology graduate students are estimated (Tatman, Peters, Greene & Bongar,
1997) to have completed biology and chemistry undergraduate coursework
considered adequate for prescribing by APA’s own ad hoc Task Force of experts
when considering possible levels of psychopharmacology training (Smyer et al.,
1993).
In contrast to other health professions, to gain admittance to current RxP
training programs, students are neither required to complete scientific
foundational course work before enrolling nor to demonstrate competence in
those domains through standardized admissions examinations (e.g., MCAT). The
Psychopharmacology Examination for Psychologists (PEP), a 150-item, multiple
choice test that is the only required testing for psychologists to prescribe
contrasts with the more comprehensive, sequential testing such as the United
States Medical Licensing Examinations (USMLE Step 1, 2 [CK and CS] and 3).
Without more extensive objective testing following rigorous coursework, it is
highly speculative to presume that the training psychologists receive could be
equivalent to that of physicians or other prescribers, or be sufficient for managing
medications, especially in people with complex comorbid conditions, such as
older adults. Without broader and in depth physical science education,
biomedical knowledge, and experiential medical training, psychologist prescribing
arguably constitutes an experiment for which there has been no objective,
systematic, or comprehensive evaluation.
Proponents of RxP summarily dismiss the importance of training that aligns
with a medical school model requiring students to have a strong foundation in the

Collaboration and Prescribing

19	
   	
  

physical sciences (McGrath, 2010). This contention contrasts with the view of
many (78.6%) psychologists, who believe that to prescribe psychologists should
have equivalent training (Baird, 2010). RxP proponents argue that because nonphysician prescribers (e.g., nurse practitioners) provide quality care that results in
health outcomes similar to that provided by physicians (e.g., comparable control
of asthma, diabetes and hypertension; health services utilization; patient
satisfaction; Mundinger et al., 2000) even though they did not attend medical
school, psychologists’ training need not be equivalent to physicians either.
However, as noted by Heiby (2010), all other non-physician prescribers typically
do have more extensive scientific (i.e., physical sciences) training at the
undergraduate level than psychologists (see Figure 1). Moreover, other
prescribers and non-prescribing disciplines have broader and more intensive
clinical medical training at the graduate level than is afforded by clinical
psychopharmacology training for psychologists.
The absence of scientific and medical training for psychologists in the
undergraduate and graduate education sequence leads to questions about how
abbreviated training after the education to become a psychologist could be
adequate to enable prescribing at levels of knowledge and competence
commensurate with other prescribers (see Table 1; Robiner et al., 2002; 2003).
The absence of any undergraduate premedical scientific prerequisites to enter
training to prescribe violates recommendations of APA’s own experts on the APA
(1992) Ad Hoc Task Force on Psychopharmacology who stipulated that:
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“…retraining of practicing psychologists for prescription
privileges would need to carefully consider selection criteria,
focusing on those psychologists with the necessary science
background…It would require students to have undergraduate
science training similar to that required of other health service
providers (e.g., nurses, pharmacists, allied health professionals,
dentists, and/or physicians). It would also require a postdoctoral
period of supervised clinical experience.” (p. 400).
The potential for insufficient medical preparation is compounded by the reality
that many psychologists train in settings outside of the health care system (e.g.,
schools, counseling centers, prisons, social service agencies). For the APA to
unilaterally determine that the basic scientific foundation required in other
prescribing professions is unnecessary for psychologists suggests an
underestimation of the complexity of the human body and drugs’ effects on it. It
also could signify inadequate respect of the contributions of those scientific
disciplines to the understanding of the mechanisms and effects of medications
whose elements are omitted. This calculation to ignore scientific foundations
assumedly derives from an objective to provide brief, affordable training so that
more practicing psychologists might complete it. Yet, even with this short cut
relatively small numbers of psychologists currently prescribe. Concerns about
the abbreviated nature of the training fuels opposition to RxP, in various other
health professions as well as among psychologists.
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Whereas the interests and competencies of psychologists and psychiatrists
overlap, there are differences in training and experience. As Steven Kingsbury,
M.D., Ph.D., a psychologist who later became a psychiatrist observed:
“Studying the effects of medications on the kidney, the heart,
and so forth is important for the use of many medications.
Managing these effects is often crucial and has more to do with
biochemistry and physiology than with psychology. I was
surprised to discover how little about medication use has to do
with psychological principles and how much of it is just medical.”
(Kingsbury, 1992, p. 5).
He also contrasted the intensity and exposure to patients in his training in
the two professions:
“In my first month of residency training in psychiatry at a
psychiatry emergency service I believe I saw more patients
individually than in my entire graduate training [i.e., in
psychology]” (Kingsbury, 1987, p. 155)
Although anecdotal, these concerns and differences are not trivial.
They are likely representative of the gaps between the medical
preparation of psychologists and that of other prescribers.
Psychologists’ Perspectives on Psychologist Prescribing
The RxP movement developed within psychology as some psychologists
sought to expand their scope of practice and, thereby, their clinical and economic
opportunities. It did not develop in response to entreaties from other health
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professions, public health officials, or consumers, and was not supported by
academic psychologists (Lavoie & Barone, 2006). Although many psychologists
support RxP in principle, unlike other professions with prescriptive authority, RxP
remains controversial among psychologists, particularly when details of
legislative proposals are considered (e.g., Hayes & Heiby, 1998; Heiby, 2002a,
2010; Robiner et al., 2002, 2003; Wagner, 2002, Walters, 2001).
Within psychology, opposing groups have included: the Society for a Science
of Clinical Psychology (2001); American Association of Applied and Preventive
Psychology (1998); Committee Against Medicalizing Psychology (CAMP; Pollitt,
2003); and most recently, Psychologists Opposed to Prescription Privileges for
Psychologists (POPPP; see www.poppp.org).
In contrast to prescribing professions, most psychologists do not intend to
prescribe (Baird, 2007; Campbell, Kearns, & Patchin, 2006), a trend that
prevents RxP from becoming a viable strategy for counteracting the shortage of
psychiatrists for which it is often touted as a remedy. Even RxP advocates
acknowledge that, “…only a minority of practitioners has evinced interest in
seeking the ability to prescribe” (Fox et al., 2009, p. 257).
Some psychologists seem to support RxP in theory, although practically
speaking express no desire to pursue training or practice; others oppose it
(Walters, 2001). Interestingly, psychologists’ understanding of the details of
prescribing training issues may be limited, so it is difficult to determine what
individual psychologists think they support if they do endorse the RxP agenda.
Baird’s (2007) survey revealed that most (78.6%) psychologists believed that to
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prescribe psychologists should receive training commensurate with other nonphysician prescribers. As noted above, APA’s current training model does not
meet that objective in terms of foundational knowledge, intensity, or breadth of
clinical experience, nor oversight through national accreditation.
Professionals’ and Consumers’ Views of Psychologist Prescribing
Although, there is consensus on the need for mental health services in the
military, and more broadly throughout society, it is unclear whether training
psychologists to prescribe is an effective means of addressing these needs.
Instead, societal needs might be better served investing resources toward
ensuring all mental health consumers have improved access to psychological
services, especially evidence-based therapies, which are typically first-line
treatments for a host of common mental health issues. For example, after
reviewing the published literature on antidepressants and other therapies, the
National Health Service in England adopted cognitive behavioral therapy as a
first-line treatment for mild and moderate depression and has invested £400
million over the next four years to increase patient access to psychotherapy to
treat depression and anxiety disorders, including plans to train up to 6,000
therapists in cognitive behavioral therapy (Center for Mental Health, 2012).
The RxP agenda is opposed by other health professionals and it undermines
interprofessional relations (Bush, 2002). The American Psychiatric Association
and the American Medical Association have consistently lobbied against it
although conceding they would have no quarrel with psychologists obtaining
prescriptive authority as mid-level medical practitioners if their training was
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equivalent to other mid-level practitioners (i.e., nurse practitioners, physician
assistants). Opposition to RxP notably extends far beyond organized medicine.
The International Society of Psychiatric-Mental Health Nurses (2001) contends
that nurses have an “ethical responsibility” to oppose RxP.
Moreover, consumers are wary of RxP. The National Alliance on Mental
Illness (NAMI), the largest mental health advocacy and support organization,
does not support RxP. NAMI’s Executive Director noted that because, “these
[psychoactive agents] are serious drugs with serious side effects…”we feel
strongly that [prescribing] should be handled by someone with medical training”
(Andrews, 2011).
Although RxP advocates claim that psychologists prescribe without problems,
there is little, if any, systematic, empirical evidence for the desirability, feasibility,
safety, and cost effectiveness of RxP (Lavoie & Barone, 2006). The unknown
consequences of relative deficits in knowledge, experience, and competence
associated with abbreviated training raise cautions (American College of
Neuropsychopharmacology, 2000; Butler et al., 2008; Robiner et al., 2003). As a
public health issue, the fundamental concerns about RxP are patient safety and
the quality of care that psychologists could deliver in prescribing relative to other
prescribing professions. Gaps in psychologists’ training to manage medications,
relative to that of other prescribers, presumably persist, even after a psychologist
might complete training conforming to the APA model.
Potential Adverse Effects and Limitations of Psychoactive Medications
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Psychoactive medications are commonly used in the treatment of anxiety,
depression, insomnia, psychosis, and other conditions, and have become more
accepted by consumers. Nevertheless, they are powerful drugs with risks for
significant adverse effects that require monitoring by qualified health
professionals who can assess their effects. This includes being prepared to
discern whether symptoms are due to the prescribed medications, to other
medications, to interactions between psychoactive medications and other
medications, or whether they might indicate other medical conditions for which
treatment is needed; not conditions for who which psychologists are trained to
assess or treat.
The potential for harm from psychoactive medications is considerable. The U.
S. Food and Drug Administration (FDA) requires black box warnings about risks
of using antipsychotics with the elderly due to increased risk of death and other
adverse effects (cardiac toxicity, stroke, infection, hyperglycemia) and for
antidepressants in adolescents and young adults due to possible increased risk
of suicidal ideation. SSRIs can cause hematological disorders, including GI and
retinal hemorrhage and other serious problems. One study found the odds of
mortality were 3.22 times higher for those using anxiolytic and hypnotic
medications in the past month (Belleville, 2010). A study of reports to the FDA
from 1998 to 2005 revealed 3-fold increases in serious morbidity and mortality
associated with adverse drug events (ADEs), with disproportionate incidence in
the elderly (Moore, Cohen, & Furberg, 2007). Two antidepressants, paroxetine
and venlafaxine, were among the agents with the most frequent, serious
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outcomes. Antipsychotics (clozapine, risperidone, olanzapaine) and paroxetine
were among drugs with most frequently suspected associated deaths.
Complications associated with psychoactive medications include cardiac
arrhythmias, insulin resistance, obesity, movement disorders, neuroleptic
malignant syndrome, serotonin syndrome, sexual dysfunctions, and adverse drug
event due to drug interactions (Stuart & Heiby, 2007). Antidepressants and
mood stabilizers account for an estimated 20,000 ADEs requiring treatment in
emergency departments (EDs; Budnitz, Pollock, Weidenbach, Mendelsohn,
Schroeder, & Annest, 2006). Antipsychotics and benzodiazepines, respectively,
accounted for 13,635 and 9,299 ADEs resulting in ED visits. The medical risks
and adverse effects associated with these agents, and the costs incurred with
care to address them, warrant that prescribers have full understanding of human
pathophysiology, morbidity, pharmacology, and the formulary beyond
psychopharmacology (Stuart & Heiby, 2007). Unfortunately, the truncated focus
of psychopharmacology training programs for psychologists raises questions
about whether the curriculum is sufficiently broad and intensive to address
patients’ overall functioning.
The rationale for RxP also is questioned as evidence mounts that
antidepressants are used to treat mild to moderate conditions for which they may
perform no better than placebo (Fournier et al., 2010), potentially resulting in
overmedication. It is unclear how knowledgeable and discerning potential
prescribing psychologists are about both the adverse effects and the bounds of
therapeutic effects. Research suggests that some claims made to clinicians and
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the public through medical journals and direct-to-consumer advertisement may
be misleading, lack sufficient empirical support (i.e., well controlled and executed
studies) and government oversight (Spielmans, Thiegles, Dent, & Greenberg,
2008), making it essential that prescribers be sufficiently educated to understand
for themselves the science underlying drugs’ action.
Controversial Issues Associated With RxP
Despite such concerns, the APA Practice Organization (APAPO) and its
affiliates have mounted campaigns lobbying state legislatures to authorize RxP to
psychologists who obtain postgraduate training based on the APA model.
Proponents contend that allowing psychologists to prescribe would expand
patient access to medications. They posit that expanding psychologists’ scope of
practice could enhance services for the underserved, such as in rural areas.
Whereas access problems do exist and warrant remedy, claims about how well
RxP would solve those problems deserve closer scrutiny and have been disputed
(Lavoie & Barone, 2006; Politt, 2003; Robiner et al., 2002).
For example, an article in the American Journal of Law & Medicine argues
that RxP advocates disingenuously mislead legislatures to grant psychologists
prescriptive authority (Pollitt, 2003). The reality is that psychologists and
psychiatrists have similar demographic distribution patterns, tending to practice in
urban and suburban areas, rather than rural areas (see Figure 2). Consequently,
RxP is not likely to meaningfully attenuate rural prescriber workforce shortages.
As noted earlier, developing interprofessional collaborations with PCPs is more
likely to improve access to psychopharmological services.
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Furthermore, mental health access issues in obtaining psychotherapeutic
interventions and psychological assessments in both rural and urban areas may
be more challenging than accessing pharmacotherapy (Campbell et al., 2006;
Westra, Eastwood, Bouffard, & Gerritsen, 2006). One study revealed that most
family practitioners thought there were psychological and psychiatric services
available in their communities for collaboration and consultation, and that they
would be reluctant to refer patients to psychologists for pharmacological
management (Bell, Digman, & McKenna, 1995). Other approaches, such as
telepsychiatry, offer the potential to compensate for some psychiatric workforce
shortages (O’Reilly et al., 2007). The shortage of psychiatrists neither logically
nor prudently leads to the conclusion that psychologists should prescribe. As
members of the “de facto” mental health system, primary care physicians and
mid-level providers can prescribe sufficiently well to meet many patients’ needs.
Enhancing the systems and intensifying the training that underlie primary care
providers’ mental health care delivery has the potential to further improve their
prescribing quality as does enhancing psychologists’ capacity to function
effectively in healthcare teams to coordinate care that is based on the interplay of
the respective clinical strengths of their disciplines.
The RxP Legislative Record
APA has allocated considerable resources to promoting RxP. By 2001, APA
had spent more than $1 million on the RxP legislative agenda (DeLeon, 2002).
The APAPO has provided grants to state psychological associations to support
RxP lobbying. The full amount that has been spent by the APA and groups of
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RxP supporters is unknown. The authors’ requests to the APAPO for financial
records related to RxP went unanswered. Conversely, the costs to counter
legislative initiatives for RxP is not known. Were RxP not a battleground, such
lobbying efforts alternatively could be used collaboratively to promote a broader
consensual agenda to advance mental health care and education within and
across disciplines.
The campaign to promote RxP has yielded modest success, which in
behavioral terms might be characterized as intermittent reinforcement,
suggesting that the RxP agenda is not likely to extinguish readily. Guam was the
first jurisdiction to pass RxP legislation in 1998. Whereas RxP proponents hail
this as an historic milestone in their movement, and widely cite it to justify
promoting legislation in other areas, it seems misleading in that none of the 14
psychologists licensed in Guam when this article was written are authorized to
prescribe. To our knowledge, this absence of an actual impact of Guam’s
legislation on patient care in Guam or on psychologists’ activities there has never
been acknowledged by RxP proponents as they have routinely cited it when
advocating for RxP in discussions with their colleagues and legislators.
New Mexico and Louisiana are the only states that have enacted RxP
legislation in 2002 and 2004, respectively. As of the writing of this article (i.e.,
about a decade after passage of enabling legislation), only 26 psychologists were
authorized to prescribe in New Mexico (another nine are considered conditional)
and only 71 in Louisiana. These numbers represent small percentages of the
licensed psychologists by psychology boards in New Mexico (3.7%; 705) and
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Louisiana (10.7%1 of 665), and a trivial fraction (0.1%) of the estimated 92,227
clinically trained psychologists nationally (Substance Abuse and Mental Health
Services Administration, 2012). A review of the medical and nursing boards’
annual reports of those states reveals that these numbers are also much smaller
than the number of advanced practice nurses (APN) and physician assistants
(PA) who can prescribe in New Mexico (1,286 APN; 688 PA) and Louisiana
(3,939 APN; 712 PA) respectively. The influence of psychologist prescribers in
addressing the medication needs in these states relative to other physician and
non-physician prescribers would appear minimal based on the numbers alone,
further raising questions about the actual impact of promoting RxP.
Prescribing psychologists’ impact on the delivery of mental health services in
those jurisdictions that authorize it has not been systematically assessed. No
large scale, objective evaluations of the impact of psychologists prescribing, or
the potential problems associated with it, have been undertaken or published. To
the authors’ knowledge, none are planned. The bounds of the “mission creep”
seeking to broaden psychology’s purview to prescribing (Heesacker, 2005) are
not known. Some proponents propose that psychologists’ formulary should
extend beyond psychopharmacology, on which the RxP movement was originally
focused, and to which psychopharmacology training is principally dedicated, to
other medications such as for weight loss, sleep disorders, chronic pain, and
nicotine addiction (Earles, James, & Folen, 2006).
Despite the expansive vision of RxP proponents, the superficial appeal of
their rhetoric, and the disproportionate attention they have garnered within the
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profession, the RxP legislative record has been lackluster. Fox et al. (2009)
estimated that at least 88 RxP legislative initiatives had been introduced in 21
jurisdictions. Using a somewhat different methodology that counts specific bills,
we estimate that 170 initiatives to authorize psychologist prescribing have been
introduced in about half of the U.S. states and two territories. Figure 3 presents
a map of RxP initiatives introduced between 1995 and 2012. Of these bills, 167
(98.2%) failed. No states have enacted RxP legislation since 2004. Some bills
have failed to garner adequate support in legislatures. Two met gubernatorial
veto. In 2013, additional bills in New Jersey and Illinois were defeated but are
not included in this analysis because they technically may still be introduced in
2013. Although a precise, cumulative tally of the lobbying and other resources
APA has marshaled to promote RxP is not available, the paltry record of
enactment of RxP legislation reveals that the RxP agenda has been costly for the
profession. We believe the record deserves psychologists’ close attention. It
raises critical questions as to whether in lobbying for the still controversial RxP
agenda professional organizations are exercising prudent stewardship of their
resources (e.g., dues revenues).
Other Effects of Promoting the RxP Agenda
Pursuing RxP arguably has diverted the profession’s attention and resources
from dealing with other matters, such as lobbying for additional funding levels for
psychological services, graduate education, scientific research and preparing for
medical homes and accountable care organizations (ACOs). It has also
distracted from focusing on the development of clinical practice guidelines and
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policies that might better meet the needs of the public and practitioners, and from
addressing other pressing professional matters (e.g., workforce, internship
imbalance, equity, health reform and healthcare redesign, licensure mobility).
Moreover, psychologists’ pursuit of RxP undermines interprofessional
relations with disciplines that oppose RxP and is divisive among psychologists.
Since just “a small minority of psychologists” has ever been expected to seek
prescription privileges (Smyer et al., 1993), APA’s and APAPO’s allocations of
resources to promote RxP have disproportionately served relatively few
psychologists, rather than the broader profession. These priorities and the
attendant stewardship of resources diminishes support for the APA among
psychologists who view the RxP as a misguided agenda and as incompatible
with their values, and/or irrelevant to their aspirations, activities and needs.
Over a decade ago, Heiby (2002b) proposed a moratorium on legislation
enabling RxP due to the absence of sound outcome data related to the training
model and the RxP movement’s divisiveness. To the authors’ knowledge only
one published study has sought to evaluate the impact, utility and safety of
prescribing psychologists in practice. Shearer and colleagues (2012) recently
surveyed 47 primary care providers and residents who worked closely with a
single (i.e., n = 1) prescribing psychologist in a family medicine clinic in an Army
medical center. Although they concluded their study provided evidence that
prescribing psychologists “practice safely and effectively” (Shearer, Harmon,
Seavey, & Tiu, 2012, p. 428), this conclusion based on essentially anecdotal data
seems premature.
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It is unclear to what degree Level-2 (i.e., Collaboration) trained psychologists,
or other psychologists, would receive similar positive ratings by providing
consultation, but not prescribing, and what additional services they could provide
if not prescribing. Additionally, as Shearer et al. note, the clear limitations in their
methodology and sample limit their ability to answer questions about
psychologist prescribing. For example, they did not ask whether it would have
been preferable to have a psychiatrist provide the psychopharmacological
consultation (in person or via telehealth) or what concerns they would have about
referring ill and complex patients. They did not assess what medical phenomena
related to prescribing psychologists might miss. Needed are more
comprehensive investigations of prescribing psychologists (e.g., in New Mexioco
and Louisiana) outside the structured setting of military facilities that yield reliable
and valid data regarding patient outcomes (i.e., safety and effectiveness) and
prescribing patterns in independent (i.e., not military) or less structured settings.
Additionally, objective, independent data that evaluate error rates in psychologist
prescribing and psychologists’ detection rates of adverse effects of medications
and that move beyond anecdotal impressions are essential to addressing
questions of whether and where prescribing psychologists provide quality care.
Similarly, assessments of whether RxP meaningfully affects access to
psychoactive medications in underserved areas is warranted.
The history of RxP provides an important case study for psychologists’ role in
promoting or supporting legislation. It clarifies that unlike other APA policies and
guidelines, the outcome of legislative initiatives is not determined by the
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preferences of APA, its council, divisions, committees, taskforces, and members,
but rather by a much broader group of stakeholders including governmental
authorities, public policy groups, other health professionals and social scientists,
consumers, as well as dissenting psychologists. In promoting legislation APA
should fully consider the risks, benefits and total capital needed to be expended
to successfully pursue its legislative priorities such that it wisely manages its
resources. The authors recommend that APA’s legislative agenda and efforts
focus on the goals and professional activities that benefit its overall membership,
rather than supporting RxP, which benefit a small, if vocal, group of psychologists.
Psychologists contribute substantively to the public health through the
provision of diverse mental health and broader health services, research, and
education, and deserve fuller recognition for the importance of their work. The
opportunities for psychologists to flourish in the dawning era of team-based
health care are before us. Psychologists’ success in this new era will be
determined by the quality of their services, their outcomes, and their capacity to
collaborate effectively. We believe the public and the profession are best served
by having psychologists provide those health services for which they are trained
rigorously (e.g., assessment, psychotherapy, consultation, supervision, research,
etc.). In many cases, psychologists are indeed the most extensively trained
among all health and mental health professionals for rendering them. As
interprofessional team-based care revolutionizes the delivery of healthcare,
refocusing the profession’s psychopharmacology agenda to better prepare
psychologists to collaborate with prescribers seems likely to be a more prudent,
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impactful, and promising strategy that would be fully in synch with broader
healthcare trends than continuing its undistinguished record in the pursuit of RxP.
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Footnotes

1

Because prescribing psychologists in Louisiana are now licensed by the

Louisiana State Board of Medical Examiners (LSBME) but still have the option of
being duly licensed by the Louisiana State Board of Examiners of

Psychologists (LSBEP) as well, we could not determine what the total
number of psychologists is in the state. Hence, the figure cited, 665, is
based on the LSBEP number data and may not include all of the psychologists.
As such, the 10.7% estimate percentage of all Louisiana psychologists who can
prescribe, is probably an overestimate of the actual proportion of prescribing
psychologists. Unfortunately, the LSBEP does not track the number of
psychologists licensed with both boards.
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Table 1
Knowledge base and clinical proficiencies required for prescribing
Psychopathology and
Psychological Issues

Medical Status Prior to
Prescribing

Response to Treatments

Primary psychiatric
conditions

Comorbid medical
conditions

Knowledge of adverse
reactions
1. Side effects
2. Toxic effects

Comorbid psychiatric
conditions

Contraindications

Ability to recognize,
diagnose, and treat
adverse reactions

Prevalence and course of Medical effects of
psychiatric conditions
concurrent treatments
1. Drug interactions
2. Other treatments
(e.g., dialysis,
plasmapheresis)

Ability to differentiate
between physical and
psychiatric effects of
psychoactive agents and
concurrent medications

Knowledge of
Nonpharmacologic
treatment options

Other issues related to
monitoring titrating, or
discontinuing prescribed
medications

Long-term effects of
medications

History of medication use
Note. The education of psychologists typically addresses column 1, but neglects
columns 2 and 3. Based on Robiner et al. (2002). Request to reprint this table
would be requested of Clinical Psychology: Science and Practice.

Figure 1
College Basic Science Prerequisite Courses for Admission to Health Science Programs
College Basic Science Prerequisite Courses 2013 - New Jersey
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Physics

40

Microbiology
Anatomy/Physiology

35
Credits

Biochemistry

30

General Biology

25

Organic Chemistry
General Chemistry

20
15
10
5
0
Nursing

Physician's
Asst.

Medicine

Podiatry

Pharmacy

Optometry

Dental Hygiene

MS Clin.
Psychopharm

Note. Multiply credits by 10 for estimated hours of instruction. These data were derived by 2013 survey of admission requirements to the largest
programs in New Jersey (e.g., Farleigh Dickinson University, University of Medicine and Dentistry of New Jersey, Rutgers University). Although
there were no physical or health sciences prerequisites for entry into the Ph.D. programs in Clinical Psychology, both the FDU and Rutgers
curriculum included one course in biopsychology or behavioral neuroscience. The MS Clinical psychopharmacology program is an example of a
program intended to train psychologists to prescribe, and requires considerably less than programs for other prescribers and non-prescribers.

Figure 2. These data show the geographic distribution comparison for psychiatrists, primary care
physicians (PCPs), and psychologists in Illinois. Data are provided for Illinois given that this state
garnered the most attention and resources from the APA during the 2013 legislative session.
Arguments for improving rural access were advanced by proponents but the data suggest similar
practice locations with more PCP in outlying rural areas. Other states present similar geographic
distributions.

Figure 3. Psychologist prescriptive authority legislative bills from 1995 through 2012

